Applied Therapeutics

Manufacturing · Michigan, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

19 Clifford St, Detroit, Michigan, 48226...

Phone Number

(800) 903-1793

Revenue

<$5 Million

Stock Symbol

APLT

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Applied Therapeutics

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. Applied Therapeutics' portfolio includes three Phase 3 programs for diseases with high unmet medical need and no approved treatment options. The Company's lead drug candidate, AT-007, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Galactosemia and SORD Deficiency. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart.Explore more
Applied Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: APLTShow more

Applied Therapeutics Org Chart

PhoneEmail
RC
United States flag for contact location.

Senior VP & Head of Marketing

PhoneEmail
AK
United States flag for contact location.

Vice President, Medical Affairs

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Applied Therapeutics

Compare insights from companies similar to Applied Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Applied Therapeutics

<$5M
11-50
Public
$99M
2016
RC
Raymond CogginsSenior VP & Head of Marketing
$17.4M
11-50
Public
-
1997
EG
Emre GokayConsulltant
$7.1M
11-50
Public
$153.3M
2000
James Dentzer, President & Chief Executive Officer at Curis
James DentzerPresident & CEO
<$5M
11-50
Public
-
2006
Terrie Kellmeyer, Interim Chief Executive Officer at Anavex Life Sciences
Terrie KellmeyerInterim CEO
<$5M
1-10
Private
-
2009
<$5M
11-50
Public
$29.8M
1997
LW
Lauren WittberAssociate Director, Accounting, SEC Reporting & Financial Analysis
<$5M
1-10
Public
$92.5M
2001
RV
Robert VenteicherSenior VP, Technical Operations
Illustration of an envelope

Applied Therapeutics Tech Stack

A closer look at the technologies used by Applied Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Applied Therapeutics

What is Applied Therapeutics's stock symbol?
Applied Therapeutics's stock symbol is APLT
What is Applied Therapeutics's official website?
Applied Therapeutics's official website is www.appliedtherapeutics.com
What is Applied Therapeutics's Revenue?
Applied Therapeutics's revenue is <$5 Million
What is Applied Therapeutics's SIC code?
Applied Therapeutics's SIC: 28,283
What is Applied Therapeutics's NAICS code?
Applied Therapeutics's NAICS: 32,325
How many employees does Applied Therapeutics have?
Applied Therapeutics has 11-50 employees
What industry does Applied Therapeutics belong to?
Applied Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Applied Therapeutics competition?
Applied Therapeutics top competitors include: Anavex Life Sciences, Oncternal Therapeutics, Curis, BBCR Consulting
What companies has Applied Therapeutics acquired?
Applied Therapeutics has acquired the companies: Applied Therapeutics, Banner Life Sciences
What technology does Applied Therapeutics use?
Some of the popular technologies that Applied Therapeutics uses are: AudioEye, DocuSign, WordPress.org, PHP
How do I contact Applied Therapeutics?
Applied Therapeutics contact info: Phone number: (800) 903-1793 Website: www.appliedtherapeutics.com
What does Applied Therapeutics do?

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. Applied Therapeutics' portfolio includes three Phase 3 programs for diseases with high unmet medical need and no approved treatment options. The Company's le... ad drug candidate, AT-007, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Galactosemia and SORD Deficiency. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart.Read More

What are Applied Therapeutics social media links?
Applied Therapeutics Linkedin page Applied Therapeutics Twitter page Applied Therapeutics Facebook page
Is Applied Therapeutics a public company?
Yes, Applied Therapeutics is a public company and is traded under the symbol APLT
See more information about Applied Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.